| Autor: |
Trappe TA; Human Performance Laboratory, Ball State University, Muncie, Indiana, United States., Minchev K; Human Performance Laboratory, Ball State University, Muncie, Indiana, United States., Perkins RK; Human Performance Laboratory, Ball State University, Muncie, Indiana, United States., Lavin KM; Human Performance Laboratory, Ball State University, Muncie, Indiana, United States., Jemiolo B; Human Performance Laboratory, Ball State University, Muncie, Indiana, United States., Ratchford SM; Human Performance Laboratory, Ball State University, Muncie, Indiana, United States., Claiborne A; Human Performance Laboratory, Ball State University, Muncie, Indiana, United States., Lee GA; Human Performance Laboratory, Ball State University, Muncie, Indiana, United States., Finch WH; Human Performance Laboratory, Ball State University, Muncie, Indiana, United States., Ryder JW; Universities Space Research Association, NASA Johnson Space Center, Houston, Texas, United States., Ploutz-Snyder L; Universities Space Research Association, NASA Johnson Space Center, Houston, Texas, United States., Trappe SW; Human Performance Laboratory, Ball State University, Muncie, Indiana, United States. |
| Abstrakt: |
The efficacy of the NASA SPRINT exercise countermeasures program for quadriceps (vastus lateralis) and triceps surae (soleus) skeletal muscle health was investigated during 70 days of simulated microgravity. Individuals completed 6° head-down-tilt bedrest (BR, n = 9), bedrest with resistance and aerobic exercise (BRE, n = 9), or bedrest with resistance and aerobic exercise and low-dose testosterone (BRE + T, n = 8). All groups were periodically tested for muscle ( n = 9 times) and aerobic ( n = 4 times) power during bedrest. In BR, surprisingly, the typical bedrest-induced decrements in vastus lateralis myofiber size and power were either blunted (myosin heavy chain, MHC I) or eliminated (MHC IIa), along with no change ( P > 0.05) in %MHC distribution and blunted quadriceps atrophy. In BRE, MHC I (vastus lateralis and soleus) and IIa (vastus lateralis) contractile performance was maintained ( P > 0.05) or increased ( P < 0.05). Vastus lateralis hybrid fiber percentage was reduced ( P < 0.05) and energy metabolism enzymes and capillarization were generally maintained ( P > 0.05), while not all of these positive responses were observed in the soleus. Exercise offsets 100% of quadriceps and approximately two-thirds of soleus whole muscle mass loss. Testosterone (BRE + T) did not provide any benefit over exercise alone for either muscle and for some myocellular parameters appeared detrimental. In summary, the periodic testing likely provided a partial exercise countermeasure for the quadriceps in the bedrest group, which is a novel finding given the extremely low exercise dose. The SPRINT exercise program appears to be viable for the quadriceps; however, refinement is needed to completely protect triceps surae myocellular and whole muscle health for astronauts on long-duration spaceflights. NEW & NOTEWORTHY This study provides unique exercise countermeasures development information for astronauts on long-duration spaceflights. The NASA SPRINT program was protective for quadriceps myocellular and whole muscle health, whereas the triceps surae (soleus) was only partially protected as has been shown with other programs. The bedrest control group data may provide beneficial information for overall exercise dose and targeting fast-twitch muscle fibers. Other unique approaches for the triceps surae are needed to supplement existing exercise programs. |
